Selected research
Market Analysis & Forecast
Global Veterinary Healthcare Market Analysis and Forecast 2026-2032
Market perspective
The global Veterinary Healthcare market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Veterinary Healthcare is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Veterinary Healthcare is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Veterinary Healthcare is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Veterinary Healthcare is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of Veterinary Healthcare include Zoetis, Virbac, Vetoquinol, Parnell, Ouro Fino Saude, Merck Animal Health, Meiji, Elanco Animal Health and Dechra Veterinary Products, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Veterinary Healthcare, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Veterinary Healthcare, also provides the revenue of main regions and countries. Of the upcoming market potential for Veterinary Healthcare, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Veterinary Healthcare revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Veterinary Healthcare market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Veterinary Healthcare revenue, projected growth trends, production technology, application and end-user industry.
Veterinary Healthcare Segment by Company
Zoetis
Virbac
Vetoquinol
Parnell
Ouro Fino Saude
Merck Animal Health
Meiji
Elanco Animal Health
Dechra Veterinary Products
Ceva
Boehringer Ingelheim
Animalcare Group
Veterinary Healthcare Segment by Type
Medicines
Vaccine
Other
Veterinary Healthcare Segment by Application
Companion Animals
Livestock Animals
Veterinary Healthcare Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Veterinary Healthcare market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Veterinary Healthcare and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Veterinary Healthcare.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Veterinary Healthcare in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Veterinary Healthcare company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Veterinary Healthcare revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Medicines
- Vaccine
- Other
Applications
- Companion Animals
- Livestock Animals
Companies covered
- Zoetis
- Virbac
- Vetoquinol
- Parnell
- Ouro Fino Saude
- Merck Animal Health
- Meiji
- Elanco Animal Health
- Dechra Veterinary Products
- Ceva
- Boehringer Ingelheim
- Animalcare Group
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Veterinary Healthcare Market by Type
- 1.2.1 Global Veterinary Healthcare Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Medicines
- 1.2.3 Vaccine
- 1.2.4 Other
- 1.3 Veterinary Healthcare Market by Application
- 1.3.1 Global Veterinary Healthcare Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Companion Animals
- 1.3.3 Livestock Animals
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Veterinary Healthcare Market Dynamics
- 2.1 Veterinary Healthcare Industry Trends
- 2.2 Veterinary Healthcare Industry Drivers
- 2.3 Veterinary Healthcare Industry Opportunities and Challenges
- 2.4 Veterinary Healthcare Industry Restraints
3 Global Growth Perspective
- 3.1 Global Veterinary Healthcare Market Perspective (2021-2032)
- 3.2 Global Veterinary Healthcare Growth Trends by Region
- 3.2.1 Global Veterinary Healthcare Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Veterinary Healthcare Market Size by Region (2021-2026)
- 3.2.3 Global Veterinary Healthcare Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Veterinary Healthcare Revenue by Players
- 4.1.1 Global Veterinary Healthcare Revenue by Players (2021-2026)
- 4.1.2 Global Veterinary Healthcare Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Veterinary Healthcare Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Veterinary Healthcare Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Veterinary Healthcare Key Players Headquarters & Area Served
- 4.4 Global Veterinary Healthcare Players, Product Type & Application
- 4.5 Global Veterinary Healthcare Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Veterinary Healthcare Market CR5 and HHI
- 4.6.3 2025 Veterinary Healthcare Tier 1, Tier 2, and Tier 3
5 Veterinary Healthcare Market Size by Type
- 5.1 Global Veterinary Healthcare Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Veterinary Healthcare Revenue by Type (2021-2032)
- 5.3 Global Veterinary Healthcare Revenue Market Share by Type (2021-2032)
6 Veterinary Healthcare Market Size by Application
- 6.1 Global Veterinary Healthcare Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Veterinary Healthcare Revenue by Application (2021-2032)
- 6.3 Global Veterinary Healthcare Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 Zoetis
- 7.1.1 Zoetis Company Information
- 7.1.2 Zoetis Business Overview
- 7.1.3 Zoetis Veterinary Healthcare Revenue and Gross Margin (2021-2026)
- 7.1.4 Zoetis Veterinary Healthcare Product Portfolio
- 7.1.5 Zoetis Recent Developments
- 7.2 Virbac
- 7.2.1 Virbac Company Information
- 7.2.2 Virbac Business Overview
- 7.2.3 Virbac Veterinary Healthcare Revenue and Gross Margin (2021-2026)
- 7.2.4 Virbac Veterinary Healthcare Product Portfolio
- 7.2.5 Virbac Recent Developments
- 7.3 Vetoquinol
- 7.3.1 Vetoquinol Company Information
- 7.3.2 Vetoquinol Business Overview
- 7.3.3 Vetoquinol Veterinary Healthcare Revenue and Gross Margin (2021-2026)
- 7.3.4 Vetoquinol Veterinary Healthcare Product Portfolio
- 7.3.5 Vetoquinol Recent Developments
- 7.4 Parnell
- 7.4.1 Parnell Company Information
- 7.4.2 Parnell Business Overview
- 7.4.3 Parnell Veterinary Healthcare Revenue and Gross Margin (2021-2026)
- 7.4.4 Parnell Veterinary Healthcare Product Portfolio
- 7.4.5 Parnell Recent Developments
- 7.5 Ouro Fino Saude
- 7.5.1 Ouro Fino Saude Company Information
- 7.5.2 Ouro Fino Saude Business Overview
- 7.5.3 Ouro Fino Saude Veterinary Healthcare Revenue and Gross Margin (2021-2026)
- 7.5.4 Ouro Fino Saude Veterinary Healthcare Product Portfolio
- 7.5.5 Ouro Fino Saude Recent Developments
- 7.6 Merck Animal Health
- 7.6.1 Merck Animal Health Company Information
- 7.6.2 Merck Animal Health Business Overview
- 7.6.3 Merck Animal Health Veterinary Healthcare Revenue and Gross Margin (2021-2026)
- 7.6.4 Merck Animal Health Veterinary Healthcare Product Portfolio
- 7.6.5 Merck Animal Health Recent Developments
- 7.7 Meiji
- 7.7.1 Meiji Company Information
- 7.7.2 Meiji Business Overview
- 7.7.3 Meiji Veterinary Healthcare Revenue and Gross Margin (2021-2026)
- 7.7.4 Meiji Veterinary Healthcare Product Portfolio
- 7.7.5 Meiji Recent Developments
- 7.8 Elanco Animal Health
- 7.8.1 Elanco Animal Health Company Information
- 7.8.2 Elanco Animal Health Business Overview
- 7.8.3 Elanco Animal Health Veterinary Healthcare Revenue and Gross Margin (2021-2026)
- 7.8.4 Elanco Animal Health Veterinary Healthcare Product Portfolio
- 7.8.5 Elanco Animal Health Recent Developments
- 7.9 Dechra Veterinary Products
- 7.9.1 Dechra Veterinary Products Company Information
- 7.9.2 Dechra Veterinary Products Business Overview
- 7.9.3 Dechra Veterinary Products Veterinary Healthcare Revenue and Gross Margin (2021-2026)
- 7.9.4 Dechra Veterinary Products Veterinary Healthcare Product Portfolio
- 7.9.5 Dechra Veterinary Products Recent Developments
- 7.10 Ceva
- 7.10.1 Ceva Company Information
- 7.10.2 Ceva Business Overview
- 7.10.3 Ceva Veterinary Healthcare Revenue and Gross Margin (2021-2026)
- 7.10.4 Ceva Veterinary Healthcare Product Portfolio
- 7.10.5 Ceva Recent Developments
- 7.11 Boehringer Ingelheim
- 7.11.1 Boehringer Ingelheim Company Information
- 7.11.2 Boehringer Ingelheim Business Overview
- 7.11.3 Boehringer Ingelheim Veterinary Healthcare Revenue and Gross Margin (2021-2026)
- 7.11.4 Boehringer Ingelheim Veterinary Healthcare Product Portfolio
- 7.11.5 Boehringer Ingelheim Recent Developments
- 7.12 Animalcare Group
- 7.12.1 Animalcare Group Company Information
- 7.12.2 Animalcare Group Business Overview
- 7.12.3 Animalcare Group Veterinary Healthcare Revenue and Gross Margin (2021-2026)
- 7.12.4 Animalcare Group Veterinary Healthcare Product Portfolio
- 7.12.5 Animalcare Group Recent Developments
8 North America
- 8.1 North America Veterinary Healthcare Revenue (2021-2032)
- 8.2 North America Veterinary Healthcare Revenue by Type (2021-2032)
- 8.2.1 North America Veterinary Healthcare Revenue by Type (2021-2026)
- 8.2.2 North America Veterinary Healthcare Revenue by Type (2027-2032)
- 8.3 North America Veterinary Healthcare Revenue Share by Type (2021-2032)
- 8.4 North America Veterinary Healthcare Revenue by Application (2021-2032)
- 8.4.1 North America Veterinary Healthcare Revenue by Application (2021-2026)
- 8.4.2 North America Veterinary Healthcare Revenue by Application (2027-2032)
- 8.5 North America Veterinary Healthcare Revenue Share by Application (2021-2032)
- 8.6 North America Veterinary Healthcare Revenue by Country
- 8.6.1 North America Veterinary Healthcare Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Veterinary Healthcare Revenue by Country (2021-2026)
- 8.6.3 North America Veterinary Healthcare Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
9 Europe
- 9.1 Europe Veterinary Healthcare Revenue (2021-2032)
- 9.2 Europe Veterinary Healthcare Revenue by Type (2021-2032)
- 9.2.1 Europe Veterinary Healthcare Revenue by Type (2021-2026)
- 9.2.2 Europe Veterinary Healthcare Revenue by Type (2027-2032)
- 9.3 Europe Veterinary Healthcare Revenue Share by Type (2021-2032)
- 9.4 Europe Veterinary Healthcare Revenue by Application (2021-2032)
- 9.4.1 Europe Veterinary Healthcare Revenue by Application (2021-2026)
- 9.4.2 Europe Veterinary Healthcare Revenue by Application (2027-2032)
- 9.5 Europe Veterinary Healthcare Revenue Share by Application (2021-2032)
- 9.6 Europe Veterinary Healthcare Revenue by Country
- 9.6.1 Europe Veterinary Healthcare Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Veterinary Healthcare Revenue by Country (2021-2026)
- 9.6.3 Europe Veterinary Healthcare Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Netherlands
- 9.6.9 Nordic Countries
10 China
- 10.1 China Veterinary Healthcare Revenue (2021-2032)
- 10.2 China Veterinary Healthcare Revenue by Type (2021-2032)
- 10.2.1 China Veterinary Healthcare Revenue by Type (2021-2026)
- 10.2.2 China Veterinary Healthcare Revenue by Type (2027-2032)
- 10.3 China Veterinary Healthcare Revenue Share by Type (2021-2032)
- 10.4 China Veterinary Healthcare Revenue by Application (2021-2032)
- 10.4.1 China Veterinary Healthcare Revenue by Application (2021-2026)
- 10.4.2 China Veterinary Healthcare Revenue by Application (2027-2032)
- 10.5 China Veterinary Healthcare Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Veterinary Healthcare Revenue (2021-2032)
- 11.2 Asia Veterinary Healthcare Revenue by Type (2021-2032)
- 11.2.1 Asia Veterinary Healthcare Revenue by Type (2021-2026)
- 11.2.2 Asia Veterinary Healthcare Revenue by Type (2027-2032)
- 11.3 Asia Veterinary Healthcare Revenue Share by Type (2021-2032)
- 11.4 Asia Veterinary Healthcare Revenue by Application (2021-2032)
- 11.4.1 Asia Veterinary Healthcare Revenue by Application (2021-2026)
- 11.4.2 Asia Veterinary Healthcare Revenue by Application (2027-2032)
- 11.5 Asia Veterinary Healthcare Revenue Share by Application (2021-2032)
- 11.6 Asia Veterinary Healthcare Revenue by Country
- 11.6.1 Asia Veterinary Healthcare Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Veterinary Healthcare Revenue by Country (2021-2026)
- 11.6.3 Asia Veterinary Healthcare Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Veterinary Healthcare Revenue (2021-2032)
- 12.2 SAMEA Veterinary Healthcare Revenue by Type (2021-2032)
- 12.2.1 SAMEA Veterinary Healthcare Revenue by Type (2021-2026)
- 12.2.2 SAMEA Veterinary Healthcare Revenue by Type (2027-2032)
- 12.3 SAMEA Veterinary Healthcare Revenue Share by Type (2021-2032)
- 12.4 SAMEA Veterinary Healthcare Revenue by Application (2021-2032)
- 12.4.1 SAMEA Veterinary Healthcare Revenue by Application (2021-2026)
- 12.4.2 SAMEA Veterinary Healthcare Revenue by Application (2027-2032)
- 12.5 SAMEA Veterinary Healthcare Revenue Share by Application (2021-2032)
- 12.6 SAMEA Veterinary Healthcare Revenue by Country
- 12.6.1 SAMEA Veterinary Healthcare Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Veterinary Healthcare Revenue by Country (2021-2026)
- 12.6.3 SAMEA Veterinary Healthcare Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst